Design of Nanodrugs
Nanodrugs phenomenal advances in nanotechnology and nanoscience have been accompanied by exciting progress in de novo design of nano sized drugs. Nanoparticles with their large space of structural amenability and excellent mechanical and electrical properties have become ideal candidates for high efficacy nanomedicines in both diagnostics and therapeutics. The therapeutic nanomedicines can be further categorized into nanoparticle drug delivery for conventional drugs and nanodrugs and nanobots with direct curing of target diseases. Here we review some of the recent advances in de novo design of nanodrugs, with an emphasis on the molecular level understanding of their interactions with biological systems including key proteins and cell membranes
Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)
Related Conference of Design of Nanodrugs
4th International Conference on Biomedicine & Pharmacotherapy
Design of Nanodrugs Conference Speakers
Recommended Sessions
- Nanobiotechnology
- Advanced Nanomedicine
- Clinical Pharmacy and Therapeutics
- Drug Targeting and Design
- Emerging technologies on Nanomedicine and Nanotechnology
- Generics and biosimilars industry strategy
- Hospital Pharmacy
- Industrial Pharmacy
- Molecular Pharmacoepidemiology
- Pharmaceutical Chemistry
- Pharmaceutical Sciences
- Pharmacological Science
- Synthesis of Nanoparticles for Drug Delivery
- Biosimilar and biologics
- Design of Nanodrugs
- Generic drugs, generic pills and generic medication
- Nano Pharmaceuticals
- Recent Nanomaterials for drug delivery